Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

C-reactive protein levels among hypertensive patients attending University of Nigeria Teaching Hospital Ituku-ozalla, Enugu State, Nigeria

Breadcrumb

  • Home
  • C-reactive Protein Levels Among Hypertensive Patients Attending University of Nigeria Teaching Hospital Ituku-ozalla, Enugu State, Nigeria
  • C-reactive protein levels among hypertensive patients attending University of Nigeria Teaching Hospital Ituku-ozalla, Enugu State, Nigeria

Kelvin Nkemakonam Orji 1, Cyprian Emeka Oguji 2, *, Ujunwa Frances Onyeama 3, Moses Ejiofor Agbo 4, Favour Chizaram Sunday 5, Victor Chisom Makata 6, Chisimdindu Frances Nnaji 6, Sharon Obianuju Eze 6 Onyinye Happiness Ike 7 and Innocent Nwabueze Okonkwo 3

1 Department of Medical Laboratory Services, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State, Nigeria.
2 Department of Medical Laboratory Services, Kaiama Referral Hospital, KOLGA, Bayelsa State, Nigeria.
3 Department of Medical Laboratory Science, University of Nigeria Enugu Campus, Enugu State, Nigeria.
4 Department of Medical Laboratory Services, Wuse General Hospital, FCT, Wuse Zone 3 Abuja, Nigeria.
5 Department of Medical Services and Training, Ministry of Health, Asaba, Delta State, Nigeria.
6 Department of Medical Laboratory Services, Enugu State University Teaching hospital Parklane, Enugu State, Nigeria.
7 Department of Medical Laboratory Services, Cottage Hospital, Okoloba, Bayelsa State, Nigeria.
Research Article
GSC Biological and Pharmaceutical Sciences, 2022, 19(03), 083–092.
Article DOI: 10.30574/gscbps.2022.19.3.0210
DOI url: https://doi.org/10.30574/gscbps.2022.19.3.0210
Received on 26 April 2022; revised on 31 May 2022; accepted on 02 June 2022
The blood level of C-reactive protein (CRP) has been postulated to increase in hypertensive patients but has not been implicated as a risk factor for high blood pressure. This prompted this study to investigate the level of CRP of hypertensive patients at the University of Nigeria Teaching Hospital, Ituku-Ozalla, and Enugu state. Eighty-nine subjects of which 50 were hypertensive patients (test subjects) and 39 apparently healthy individuals (control subjects) volunteered in the study. A structured questionnaire was used to capture the bio-data and other vital information from the participants of which virtually all the test subjects were on anti-hypertensive drugs. Anthropometric measurements were taken, blood samples were collected and CRP was analyzed using the Enzyme-Linked Immunosorbent Assay method. Data were analyzed using the student's test and Analysis of Variance (ANOVA). There was no significant statistical difference (P>0.05) in CRP levels (µg/ml) in all the comparisons; that is between all male and female study populations (401-478 and 3.61-4.24), between tests and controls (3.62-3.85 and 4.06-526), between male tests and male controls (3.76-3.55 and 4.24-5.80), between female tests and female control (3.62 ±3.85 and 3.76-3.55) between male tests and female tests (3.50-414 and 381-4.531, and between male controls and female controls (4.24 ±5.80 and 3.81-4.55). It was also observed that there was no relationship between the duration of hypertension with the CRP levels in the test subjects. These results suggest that the C-reactive protein levels may be increased in hypertensive patients but may be decreased by antihypertensive therapies. More studies are needed and these findings warrant further evaluation in randomized trials. A longitudinal study to fully assess the effect of antihypertensive drugs on the level of C-reactive protein in hypertensive patients may also be of great essence. 
C - reactive protein; Hypertension; Blood Pressure; Antihypertensive Drugs; Hypertensive Patients
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2022-…

Preview Article PDF

Kelvin Nkemakonam Orji, Cyprian Emeka Oguji, Ujunwa Frances Onyeama, Moses Ejiofor Agbo, Favour Chizaram Sunday, Victor Chisom Makata, Chisimdindu Frances Nnaji, Sharon Obianuju Eze, Onyinye Happiness Ike and Innocent Nwabueze Okonkwo. C-reactive protein levels among hypertensive patients attending University of Nigeria Teaching Hospital Ituku-ozalla, Enugu State, Nigeria. GSC Biological and Pharmaceutical Sciences, 2022, 19(3), 083-092. Article DOI: https://doi.org/10.30574/gscbps.2022.19.3.0210


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution